Michael Jelinek to Cetuximab
This is a "connection" page, showing publications Michael Jelinek has written about Cetuximab.
Connection Strength
0.221
-
Current State and Future Directions of EGFR-Directed Therapy in Head and Neck Cancer. Curr Treat Options Oncol. 2023 06; 24(6):680-692.
Score: 0.221
Connection Strength
The connection strength for concepts is the sum of the scores for each matching publication.
Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.